Akut mieloid leukémia (AML): vizsgálatok itt: Egyesült Államok
334 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in Egyesült ÁllamokA Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant
- Where
- Milwaukee
- Életkor
- 18 év and over
- People
- 450
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07572929 - No phaseNot yet taking people in Egyesült ÁllamokImproving Delivery of Aging-Related Supportive Care for Older Adults With Acute Myeloid Leukemia
- Where
- Birmingham
- Életkor
- 18 év and over
- People
- 40
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07777471 - No phaseTaking peopleLongitudinal Studies of Patient With FPDMM
- Where
- Bethesda
- Életkor
- 1 nap to 100 év
- People
- 1000
- Run by
- National Human Genome Research Institute (NHGRI)
See details and how to joinNCT03854318 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Atlanta, Aurora, Boston, Chicago, Cincinnati, Columbus, Duarte, Durham, Hackensack, Houston, Iowa City, Los Angeles, New York, Palo Alto, Philadelphia, Portland, Salt Lake City, Sarasota, St Louis, Tampa
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1. fázisTaking peopleDecitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission
- Where
- Houston
- Életkor
- 18 év and over
- People
- 125
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05010772 - 1. fázisTaking peopleZiftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Where
- Atlanta, Aurora, Boston, Chicago, Cincinnati, Houston, Los Angeles, Memphis, New York, Philadelphia, Seattle
- Életkor
- 0 év to 21 év
- People
- 20 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT06376162 · EU 2023-505262-28-00 - 1. fázisTaking peopleA Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
- Where
- Houston, Tampa
- Életkor
- 18 év and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06616636 - No phaseTaking peopleA Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- Where
- Bethesda, Charlotte, Cincinnati, Columbus, Fargo, Iowa City, Maumee, Reno, Rochester, Sioux Falls, St Louis, York
- Életkor
- 0 év and over
- People
- 550
- Run by
- Tempus AI
See details and how to joinNCT07154823 - 2. fázisNot yet taking people in Egyesült ÁllamokPhase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AML
- Where
- New Brunswick
- Életkor
- 18 év and over
- People
- 41
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT07867626 - 1/2. fázisTaking peopleDecitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
- Where
- Cleveland
- Életkor
- 18 év and over
- People
- 20
- Run by
- Benjamin Tomlinson
See details and how to joinNCT06129734 - 2. fázisTaking peopleEfficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
- Where
- Houston
- Életkor
- 18 év and over
- People
- 112
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT07060001 - 1. fázisTaking peopleZiftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
- Where
- Boston
- Életkor
- 12 év and over
- People
- 24
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07355335 - 2. fázisTaking peopleTotal Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 35
- Run by
- City of Hope Medical Center
See details and how to joinNCT07582172 - 2. fázisTaking peopleFludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Életkor
- 18 év and over
- People
- 270
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT00801489 - 1/2. fázisTaking peopleAzacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- Where
- Houston
- Életkor
- 18 év and over
- People
- 97
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04140487 - 2/3. fázisTaking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Atlanta, Boston, Buffalo, Charleston, Columbus, Dallas, Durham, Hackensack, Houston, Los Angeles, Miami, Milwaukee, Mineola, Nashville, New Haven, New York, Orange, Portland, Salem, Seattle, The Bronx
- Életkor
- 18 év and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - 1. fázisTaking peopleA Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Életkor
- 1 év and over
- People
- 15
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06017258 - 1. fázisTaking peopleZiftomenib Maintenance Post Allo-HCT
- Where
- Boston, Columbus
- Életkor
- 18 év and over
- People
- 22
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06440135 - 2. fázisTaking peopleMonitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study
- Where
- Houston
- Életkor
- 18 év and over
- People
- 140
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06811233 - 2. fázisTaking peopleA Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Életkor
- 60 év and over
- People
- 45
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07392242 - No phaseTaking peopleIndividualized AML Treatment
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 20
- Run by
- City of Hope Medical Center
See details and how to joinNCT07613385 - 2. fázisTaking peopleVenetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- Where
- Houston
- Életkor
- 50 év and over
- People
- 145
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03586609 - Korai 1. fázisTaking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - 2. fázisTaking peopleIvosidenib as Post-HSCT Maintenance for AML
- Where
- Atlanta, Boston, Columbus, Kansas City, Milwaukee, Salt Lake City
- Életkor
- 18 év to 75 év
- People
- 75
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06707493 - 1. fázisTaking peopleA Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Atlanta, Dallas, Nashville, Palo Alto, Valhalla
- Életkor
- 6 hónap to 17 év
- People
- 18 worldwide
- Run by
- AbbVie
See details and how to joinNCT07306832